Efficacy of Tofacitinib as an Induction Agent in Severe Alopecia Areata Compared to Oral Betamethasone Weekly Pulse
April 2024
in “
Clinical and experimental dermatology
”

TLDR Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.
The study evaluates the efficacy of tofacitinib as an induction agent for severe alopecia areata (AA), characterized by ≥ 50% scalp hair loss, in comparison to the standard oral mini-pulse (OMP) therapy. The findings suggest that tofacitinib is a promising induction agent for patients with severe AA, showing comparable results to OMP. However, for patients who do not respond adequately to tofacitinib, a trial of pulse steroids may be considered as an alternative treatment option.